Research Article
Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
Table 1
Demographic data and disease characteristics of the patients
.
| | Gender | 13 women/4 men |
| | Age | | | Mean ± SD | 56 ± 15 | | Median (range) | 60 (28–73) | | Years since diagnosis | | | Mean ± SD | 5 ± 3 | | Median (range) | 4 (1–12) | | Marital status | | | Single | 5 | | Married/living together | 12 | | Education | | | Elementary school | 4 | | High school | 6 | | College/university | 7 | | Diagnosis | | | IPAH1 | 6 | | APAH2 | 1 | | IPAH + APAH | 1 | | APAH + SSC3 | 4 | | CTEPH4 | 3 | | CTEPH with surgery | 2 | | Drugs | | | ERAa + PDEb + warfarin | 7 | | ERA + PDE | 4 | | ERA | 1 | | ERA + Warfarin | 1 | | ERA + CCBc + warfarin | 1 | | CCB | 1 | | PDE | 1 | | PDE + warfarin | 1 | | Current occupation | | | Full time job | 3 | | Part time job | 5 | | Disability/retirement pension | 9 |
|
|
1Idiopathic pulmonary arterial hypertension.
2Associated pulmonary arterial hypertension.
3Sclerosis-associated pulmonary arterial hypertension.
4Chronic thromboembolic pulmonary hypertension.
aEndothelin receptor antagonists.
bPhosphodiesterase.
cCalcium channel blockers.
|
